Clinical Trials Browser

Neuroblastoma × Sorafenib × 90 days × Clear all

NCT02559778 2026-04-28

PEDS-PLAN

Phase 2 Recruiting

Neuroblastoma

NCT02298348 2026-03-23

N2013-02

Phase 1 Active not recruiting

Neuroblastoma, Recurrence